Items where Author is "Vey, N"

Journal article

UY, G.L., ALDOSS, I., FOSTER, M.C., SAYRE, P.H., WIEDUWILT, M.J., ADVANI, A.S., GODWIN, J.E., ARELLANO, M.L., SWEET, K., EMADI, A., RAVANDI, F., ERBA, H.P., BYRNE, M., MICHAELIS, L.C., TOPP, M.S., VEY, N., CICERI, F., CARRABBA, M.G., PAOLINI, S., HULS, G., JONGEN-LAVRENCIC, M., WERMKE, M., CHEVALLIER, P., GYAN, E., RÉCHER, C., STIFF, P., PETTIT, K., LÖWENBERG, B., CHURCH, S., ANDERSON, E.K., VADAKEKOLATHU, J., SANTAGUIDA, M.T., RETTIG, M.P., MUTH, J., CURTIS, T., FEHR, E., GUO, K., ZHAO, J., BAKKACHA, O., JACOBS, K., TRAN, K., KAMINKER, P., KOSTOVA, M., BONVINI, E., WALTER, R.B., DAVIDSON-MONCADA, J.K., RUTELLA, S. and DIPERSIO, J.F., 2020. Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. Blood. ISSN 0006-4971

UY, G.L., RETTIG, M.P., VEY, N., GODWIN, J., FOSTER, M.C., RIZZIERI, D.A., ARELLANO, M.L., TOPP, M.S., HULS, G., JONGEN-LAVRENCIC, M., MARTINELLI, G., PAOLINI, S., CICERI, F., CARRABBA, M.G., SWEET, K.L., RAVANDI, F., CHURCH, S.E., VADAKEKOLATHU, J., RUTELLA, S., SUN, J., YANG, K., BAUGHMAN, J., CURTIS, T., TIMMENY, E., CALI, K., TRAN, K., MUTH, J., LA MOTTE-MOHS, R., POIROT, C., PALLIS, A., CESANO, A., BONVINI, E., WIGGINGTON, J., LOWENBERG, B., DAVIDSON-MONCADA, J.K. and DIPERSIO, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971